drugset / Trial / NCT05613127
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate immunogenicity and safety of inactivated hepatitis A vaccine in healthy children aged from 24 months to 15 years when administered an initial dose followed by a booster dose (a total of 2 doses administered with 6 months interval).
Timeline
- Start
- 2022-12
- Primary completion
- 2024-07
- Completion
- 2024-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Boryung Hepatitis A Vaccine | Vaccine | 0.5 ml | Intramuscular |
| Comparator | HAVRIX 720 Junior | Vaccine | 0.5 ml | Intramuscular |